Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Aug 29, 2024 4
4 Aug 29, 2024 4
4 Aug 6, 2024 4
S-8 Aug 5, 2024 S-8
10-Q Aug 5, 2024 10-Q
8-K Aug 5, 2024 8-K
8-K Jun 3, 2024 8-K
4 May 30, 2024 4
4 May 30, 2024 4
4 May 30, 2024 4
4 May 30, 2024 4
4 May 30, 2024 4
4 May 30, 2024 4
4 May 30, 2024 4
4 May 30, 2024 4
8-K May 15, 2024 8-K
10-Q May 15, 2024 10-Q
ARS Apr 16, 2024 ARS
DEFA14A Apr 16, 2024 DEFA14A
DEF 14A Apr 16, 2024 DEF 14A
8-K Mar 29, 2024 8-K
EFFECT Mar 22, 2024
CORRESP Mar 20, 2024
UPLOAD Mar 20, 2024
S-3 Mar 15, 2024 S-3
← Newer Page 4 of 21 · 513 filings Older →